Healey meets with biotech startups to hear about financing needs
The biotech industry is in full swing, with deals activity happening at a breakneck pace and investors’ dollars pouring into new treatments. But there’s one important segment getting left behind: early-stage biotech firms, many with fewer than 10 employees …